Successful transcatheter aortic valve replacement in a kidney allograft patient on rapamycin

Abstract

Aortic valvular stenosis producing hemodynamic compromise is a major determinant of allograft function in kidney transplant recipients. Here, we describe successful transcatheter aortic valve replacement in a 59-year-old patient who had a kidney transplantation 14 years ago on 3 drug maintenance immunosuppression, including rapamycin.

Keywords

• aortic valve stenosis
• kidney transplantation
• rapamycin
• transcatheter aortic valve replacement